BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 20538001)

  • 41. Effect of DL-alpha-difluoromethylornithine on polyamine synthesis and interconversion in Trichomonas vaginalis grown in a semi-defined medium.
    Yarlett N; Bacchi CJ
    Mol Biochem Parasitol; 1988 Oct; 31(1):1-9. PubMed ID: 3141809
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Independent roles of eIF5A and polyamines in cell proliferation.
    Nishimura K; Murozumi K; Shirahata A; Park MH; Kashiwagi K; Igarashi K
    Biochem J; 2005 Feb; 385(Pt 3):779-85. PubMed ID: 15377278
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polyamines and the calcium paradox in rat hearts.
    Busselen P
    J Mol Cell Cardiol; 1991 Mar; 23(3):237-47. PubMed ID: 1908906
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of difluoromethylornithine on decreasing prostate size and polyamines in men: results of a year-long phase IIb randomized placebo-controlled chemoprevention trial.
    Simoneau AR; Gerner EW; Nagle R; Ziogas A; Fujikawa-Brooks S; Yerushalmi H; Ahlering TE; Lieberman R; McLaren CE; Anton-Culver H; Meyskens FL
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):292-9. PubMed ID: 18268112
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polyamines as biomarkers of cervical intraepithelial neoplasia.
    Nishioka K; Melgarejo AB; Lyon RR; Mitchell MF
    J Cell Biochem Suppl; 1995; 23():87-95. PubMed ID: 8747382
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polyamines as mediators of APC-dependent intestinal carcinogenesis and cancer chemoprevention.
    Rial NS; Meyskens FL; Gerner EW
    Essays Biochem; 2009 Nov; 46():111-24. PubMed ID: 20095973
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of polyamine formation antagonizes vascular smooth muscle cell proliferation and preserves the contractile phenotype.
    Grossi M; Persson L; Swärd K; Turczyńska KM; Forte A; Hellstrand P; Nilsson BO
    Basic Clin Pharmacol Toxicol; 2014 Nov; 115(5):379-88. PubMed ID: 24666424
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Failure of ornithine decarboxylase inhibition to alter small intestinal epithelial repair after transient segmental ischaemia.
    Guzman C; MacLeod RJ; Hamilton JR
    Gut; 1988 Jul; 29(7):935-40. PubMed ID: 3135252
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship between heat sensitivity and polyamine levels after treatment with alpha-difluoromethylornithine (DFMO).
    Mivechi NF; Dewey WC; Feuerstein BG; Deen DF; Marton LJ
    Radiat Res; 1986 Dec; 108(3):269-81. PubMed ID: 3099327
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polyamines, PI(4,5)P2, and actin polymerization.
    Coburn RF; Labelle EF; Baron CB
    J Cell Physiol; 2006 Nov; 209(2):405-12. PubMed ID: 16883568
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urinary and erythrocyte polyamines during the evaluation of oral alpha-difluoromethylornithine in a phase I chemoprevention clinical trial.
    Pendyala L; Creaven PJ; Porter CW
    Cancer Epidemiol Biomarkers Prev; 1993; 2(3):235-41. PubMed ID: 8318876
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combination chemoprevention of intestinal carcinogenesis in a murine model of familial adenomatous polyposis.
    Ignatenko NA; Besselsen DG; Stringer DE; Blohm-Mangone KA; Cui H; Gerner EW
    Nutr Cancer; 2008; 60 Suppl 1():30-5. PubMed ID: 19003578
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of difluoromethylornithine as a chemoprevention agent for the management of colon cancer.
    Meyskens FL; Gerner EW
    J Cell Biochem Suppl; 1995; 22():126-31. PubMed ID: 8538189
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhanced antitumor efficacy with a combination of hyperthermochemotherapy and thermosensitization with polyamine antimetabolites in nude mice.
    Fujimoto S; Shrestha RD; Ohta M; Igarashi K; Endoh F; Kokubun M; Koike S; Togawa Y; Okui K
    Jpn J Surg; 1987 Mar; 17(2):110-7. PubMed ID: 3114528
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of ornithine decarboxylase activity decreases polyamines and suppresses DNA synthesis in human colonic lamina propria lymphocytes.
    Elitsur Y; Strom J; Luk GD
    Immunopharmacology; 1993; 25(3):253-60. PubMed ID: 8354641
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alpha-difluoromethylornithine as treatment for metastatic breast cancer patients.
    O'Shaughnessy JA; Demers LM; Jones SE; Arseneau J; Khandelwal P; George T; Gersh R; Mauger D; Manni A
    Clin Cancer Res; 1999 Nov; 5(11):3438-44. PubMed ID: 10589756
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Luminal polyamines stimulate repair of gastric mucosal stress ulcers.
    Wang JY; Johnson LR
    Am J Physiol; 1990 Oct; 259(4 Pt 1):G584-92. PubMed ID: 1699428
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Polyamines in brain and heart of the neonatal rat: effects of inhibitors of ornithine decarboxylase and spermidine synthase.
    Slotkin TA; Bartolome J; Persons D; Whitmore WL
    Life Sci; 1984 Sep; 35(10):1125-31. PubMed ID: 6434889
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Luminal polyamines substitute for tissue polyamines in duodenal mucosal repair after stress in rats.
    Wang JY; Johnson LR
    Gastroenterology; 1992 Apr; 102(4 Pt 1):1109-17. PubMed ID: 1551519
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacological and dietary agents for colorectal cancer chemoprevention: effects on polyamine metabolism (review).
    Linsalata M; Orlando A; Russo F
    Int J Oncol; 2014 Nov; 45(5):1802-12. PubMed ID: 25119812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.